Nucleoside analogues are widely used as effective antiviral drugs. The continuous emergence of pathogenic viruses calls for novel and structurally diverse nucleoside analogues. Herein, we report a divergent synthesis of highly bioactive and non-cytotoxic nucleoside analogues with an unprecedented carbobicyclic core. In our step-economic synthesis, a Mitsunobu reaction and an intermolecular Diels-Alder reaction rapidly create a focused library of regio- and stereo-divergent analogues. In our evaluations against the respiratory syncytial virus, we found these analogues to be up to 16 times more potent than ribavirin, an FDA-approved antiviral nucleoside analogue. Importantly, the carbobicyclic core structure is critical for the potent antiviral activity, thus opening up ample opportunities for further lead optimization and mechanistic investigations.